// App-Quantinova.ai

1265 : Dysregulated tyrosine kinase Tyro3 signaling in acute myeloid leukemia

Researchers

Presenter

  • Fatma Eryildiz

Principal Investigators

  • Jeffrey W. Tyner

Medical Centers

  • OHSU Institute of Environmental Health, Portland, OR

  • Knight Cancer Institute, Portland, OR

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

  • Hematological malignancies

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved